Clinical Trials Directory

Trials / Sponsors / RVL Pharmaceuticals, Inc.

RVL Pharmaceuticals, Inc.

Industry · 10 registered clinical trials — 1 currently recruiting.

StatusTrialPhaseStarted
Not Yet RecruitingA Study to Investigate Arbaclofen ER Tablets for the Treatment of Spasticity in Patients With Multiple Scleros
Spasticity
Phase 32027-01-01
CompletedStudy of Safety and Efficacy of RVL-1201 in the Treatment of Blepharoptosis
Blepharoptosis
Phase 32018-06-28
CompletedStudy of Safety of RVL-1201 in Treatment of Blepharoptosis
Blepharoptosis
Phase 32018-06-20
CompletedA Study to Evaluate the Long-term Safety of Arbaclofen Extended-Release Tablets for Patients With Spasticity D
Multiple Sclerosis, Spasticity, Muscle
Phase 32018-04-03
CompletedA Study to Investigate the Safety and Effectiveness of Arbaclofen Extended-Release Tablets for Patients With M
Multiple Sclerosis, Spasticity, Muscle
Phase 32018-01-28
WithdrawnTo Assess Effects of Arbaclofen ER Tablets Compared With Placebo on Sperm Parameters in Male Subjects With MS
Multiple Sclerosis, Sperm
Phase 32016-07-01
CompletedStudy of the Safety and Efficacy of RVL-1201 in the Treatment of Acquired Blepharoptosis
Acquired Blepharoptosis
Phase 32015-05-01
CompletedSafety and Efficacy Study of RVL-1201 in Acquired Blepharoptosis
Blepharoptosis
Phase 1 / Phase 22013-05-01
CompletedOne Year, Open Label, Dose Escalation Long-term Safety Study in Multiple Sclerosis (MS) Subjects With Spastici
Multiple Sclerosis, Spasticity
Phase 32013-04-01
CompletedEfficacy Study of Arbaclofen to Treat Spasticity in Multiple Sclerosis
Spasticity, Multiple Sclerosis
Phase 32012-11-01